Public Profile

Morepen

Morepen Laboratories Limited, commonly known as Morepen, is a prominent player in the pharmaceutical and healthcare industry, headquartered in India. Established in 1984, the company has made significant strides in the development and manufacturing of a diverse range of products, including diagnostic kits, active pharmaceutical ingredients (APIs), and over-the-counter medications. With a strong operational presence across India and various international markets, Morepen is recognised for its commitment to quality and innovation. The company’s core offerings, such as its advanced diagnostic solutions and high-quality APIs, set it apart in a competitive landscape. Morepen's dedication to research and development has earned it a notable position in the market, reflecting its ongoing pursuit of excellence in healthcare solutions.

DitchCarbon Score

How does Morepen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

16

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Morepen's score of 16 is lower than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.

4%

Let us know if this data was useful to you

Morepen's reported carbon emissions

In 2023, Morepen reported total carbon emissions of approximately 17,576,050 kg CO2e from Scope 1 and 12,928,850 kg CO2e from Scope 2, amounting to a combined total of about 30,504,900 kg CO2e. This represents a significant increase from 2024, where emissions rose to approximately 31,403,010 kg CO2e for Scope 1 and 16,412,460 kg CO2e for Scope 2, totalling around 47,815,470 kg CO2e. Morepen has disclosed emissions data for Scope 1 and Scope 2 but has not provided information on Scope 3 emissions. The company has not set specific reduction targets or climate pledges, indicating a potential area for future commitment. The emissions intensity per rupee of turnover adjusted for Purchasing Power Parity (PPP) was reported at 0.00502 for 2023 and 0.00686 for 2024, reflecting the company's operational efficiency in relation to its revenue. Overall, while Morepen has made strides in tracking its emissions, the absence of reduction targets suggests an opportunity for enhanced climate action and commitment to sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20232024
Scope 1
17,576,050
00,000,000
Scope 2
12,928,850
00,000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Morepen's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Morepen is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Morepen is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Supriya Lifescience Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Ind-Swift Limited

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Neuland Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hikal

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Ind-Swift

IN
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers